Oric Pharmaceuticals: RAHD proposes $102K share sale

The 7,600 shares were acquired from Oric Pharmaceuticals, Inc. in a private investment on July 31, 2015, for cash.

Rhea-AI Filing Summary

Oric Pharmaceuticals, Inc. (ORIC) is identified as the issuer in a notice covering a proposed sale of 7,600 common shares by RAHD Capital, LLC; Richard A. Heyman, a director, is named as the LLC’s manager. J.P. Morgan Securities LLC is listed as broker, and the notice gives an approximate sale date of October 1, 2026, and an aggregate market value of $102,372.

Key Figures

Proposed common shares: 7,600 shares Aggregate market value: $102,372 Shares outstanding: 103,652,656 shares +1 more

4 metrics

Proposed common shares 7,600 shares Proposed sale by RAHD Capital, LLC

Aggregate market value $102,372 Proposed sale

Shares outstanding 103,652,656 shares Issuer shares outstanding as listed in the securities information

Previously acquired shares 7,600 shares Private investment from the issuer on July 31, 2015, for cash

Key Terms

Rule 144, Aggregate market value, Private Investment, shares outstanding

4 terms

Rule 144 regulatory

"definition of "person" in paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Aggregate market value financial

"Aggregate market value"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

Private Investment financial

"07/31/2015 | Private Investment | Issuer"

shares outstanding financial

"Number of shares or other units outstanding"

Shares outstanding are the total number of a company’s stock units held by all shareholders, including institutional investors and company insiders — think of them as the total number of slices of the company’s ownership pie. Investors use this number to calculate how much of the company each share represents, and it directly affects per-share measures like earnings per share, ownership percentage and valuation; when the slice count changes, an investor’s claim and the company’s per-share metrics change too.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ORIC shares does RAHD Capital plan to sell?

RAHD Capital, LLC is identified as selling 7,600 common shares, with Richard A. Heyman, a director, named as its manager. J.P. Morgan Securities LLC is listed as the broker, and the approximate sale date is October 1, 2026.

What prior ORIC sales are listed for the past three months?

Past-three-month records list 150 shares by RAHD Capital, LLC on July 6, 2026, for $1,800 and 6,250 shares on July 24, 2026, for $75,128. They also list 150 shares by Richard A. Heyman on July 6, 2026, for $1,800 and 6,850 shares on July 24, 2026, for $82,340.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/01/2026 - 04:23 PM Accepted by SEC EDGAR 10/01/2026 - 04:23 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001584759
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Oric Pharmaceuticals, Inc.
SEC File Number	001-39269
Address of Issuer	240 E. Grand Ave 2nd Floor San Francisco CALIFORNIA 94080
Phone	6503885600
Name of Person for Whose Account the Securities are To Be Sold	Richard A, Heyman
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	J.P. Morgan Securities LLC 270 Park Avenue 10th Floor New York NY 10017	7600	102372	103652656	10/01/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/31/2015	Private Investment	Issuer			7600	07/31/2015	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
RAHD Capital, LLC 240 E. GRAND AVE. 2nd Floor SOUTH SAN FRANCISCO CA 94080	Common	07/06/2026	150	1800
RAHD Capital, LLC 240 E. GRAND AVE. 2nd Floor SOUTH SAN FRANCISCO CA 94080	Common	07/24/2026	6250	75128
Richard Heyman 240 E. GRAND AVE. 2nd Floor SOUTH SAN FRANCISCO CA 94080	Common	07/06/2026	150	1800
Richard Heyman 240 E. GRAND AVE. 2nd Floor SOUTH SAN FRANCISCO CA 94080	Common	07/24/2026	6850	82340

144: Remarks and Signature

Remarks	The shares filed today will be sold by RAHD Capital, LLC, Richard A. Heyman as Manager.
Date of Notice	10/01/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/26/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for Richard A. Heyman.
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)